Endo International (ENDP 5) and Allergan (AGN 6) are in talks to avoid going to a landmark trial set to begin in October over the opioid crisis, ...
Pharmalittle: Two drug makers may settle opioid case; FDA hands Sarepta a surprising setback
- Written by: Drug News Feed
- Category: Drug News
- Hits: 585